Rupison Pharmaceuticals Private Limited
About Rupison Pharmaceuticals Private Limited
Data last updated:
Rupison Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 25 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2018PTC105641. Its GSTIN is 09AAJCR0178C1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dev Karan and Shiv Karan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 22 Nagla Jagmohan Dauki, Agra, Uttar Pradesh, India – 283111.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.61 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹322 (net margin 0%) and EBITDA of ₹12,863 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 14% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address22 Nagla Jagmohan Dauki, Agra, Uttar Pradesh, India – 283111
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rupison Pharmaceuticals Private Limited
The main business activity of Rupison Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rupison Pharmaceuticals Private Limited FY 2025 filings available
Rupison Pharmaceuticals Private Limited reported revenue of ₹16.61 Lakh (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rupison Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 24% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rupison Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12,863 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹322 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rupison Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rupison Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rupison Pharmaceuticals Private Limited
Rupison Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shirama Pharmaceuticals Private Limited | ₹16.84 Lakh (FY 2024) | •••• | •••• | 85.0% | •••• | Varanasi, Uttar Pradesh, India |
| Turio Pharmaceuticals Private Limited | ₹16.81 Lakh (FY 2024) | •••• | •••• | 1265.0% | •••• | Hyderabad, Telangana, India |
| Osbone Pharmaceuticals Private Limited | ₹16.8 Lakh (FY 2020) | •••• | •••• | 577.0% | •••• | Indore, Madhya Pradesh, India |
| Ravnil Pharmaceuticals Private Limited | ₹16.8 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Indore, Madhya Pradesh, India |
| Amaresha Pharmaceuticals Private Limited | ₹16.64 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Chennai, Tamil Nadu, India |
| Rupison Pharmaceuticals Private Limited this company | ₹16.61 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Agra, Uttar Pradesh, India |
| Healia Pharmaceuticals Private Limited | ₹16.6 Lakh (FY 2021) | •••• | •••• | -24.0% | •••• | Palakkad, Kerala, India |
| Racmose Pharmaceuticals Private Limited | ₹16.55 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Delhi, India |
| Seraphim Pharmaceuticals Private Limited | ₹16.55 Lakh (FY 2025) | •••• | •••• | -54.0% | •••• | New Delhi, Delhi, India |
| Ramington Pharmaceuticals Private Limited | ₹16.55 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Ambala Cantt, Haryana, India |
| Arisen Pharmaceuticals India Private Limited | ₹16.54 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | Kasaragod, Kerala, India |
Peers are the five companies nearest above and the five nearest below Rupison Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Rupison Pharmaceuticals Private Limited
Rupison Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dev Karan | Director | 25 Jun 2018 | 8 Years 3 Months | Current |
| Shiv Karan | Director | 25 Jun 2018 | 8 Years 3 Months | Current |
Ownership and Shareholding of Rupison Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rupison Pharmaceuticals Private Limited
Rupison Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rupison Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Rupison Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rupison Pharmaceuticals Private Limited
Rupison Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Dev Karan was appointed as Director on 25 Jun 2018.
Credit Ratings, Litigation & Regulatory Alerts for Rupison Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rupison Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rupison Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rupison Pharmaceuticals Private Limited
Rupison Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCR0178C1ZF | Uttar Pradesh | Active | 04 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rupison Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupison Pharmaceuticals Private Limited
Rupison Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 25 June 2018 (8+ years old) and is registered under CIN U74999UP2018PTC105641.
Rupison Pharmaceuticals reported revenue of ₹16.61 Lakh for FY 2025 (up 24% YoY).
Rupison Pharmaceuticals has 2 current directors:
- Dev Karan - Director
- Shiv Karan - Director
Rupison Pharmaceuticals reported a net profit of ₹322 (net margin 0%) and EBITDA of ₹12,863 (EBITDA margin 0.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rupison Pharmaceuticals is -1% over three years and 14% over five years. In the latest year (FY 2025) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rupison Pharmaceuticals is 09AAJCR0178C1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Rupison Pharmaceuticals is U74999UP2018PTC105641. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rupison Pharmaceuticals was incorporated on 25 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Rupison Pharmaceuticals by revenue are Shirama Pharmaceuticals Private Limited, Turio Pharmaceuticals Private Limited, Osbone Pharmaceuticals Private Limited, Ravnil Pharmaceuticals Private Limited, Amaresha Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Dev Karan was appointed as Director on 25 Jun 2018. Shiv Karan was appointed as Director on 25 Jun 2018.
The registered office of Rupison Pharmaceuticals is at 22 Nagla Jagmohan Dauki, Agra, Uttar Pradesh, India – 283111.